Silvant Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Silvant Capital Management LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $147.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$147.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 112,338 | $103.3M |
| CORCencora Inc. | 32,185 | $10.1M |
| IDXXIDEXX LABORATORIES INC /DE | 13,248 | $7.4M |
| MCKMcKesson Corporation | 7,881 | $6.8M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 18,258 | $6.0M |
| INSMINSMED Inc | 19,905 | $3.3M |
| MRKMerck & Co., Inc. | 25,811 | $3.1M |
| NBIXNEUROCRINE BIOSCIENCES INC | 20,606 | $2.7M |
| ZTSZoetis Inc. | 8,762 | $1.0M |
| ABBVAbbVie Inc. | 4,037 | $878K |
| JNJJOHNSON & JOHNSON | 2,471 | $604K |
| PMPhilip Morris International Inc | 3,212 | $531K |
| AMGNAMGEN INC | 1,245 | $438K |
| BMYBRISTOL MYERS SQUIBB CO | 5,887 | $357K |
| PFEPFIZER INC | 9,981 | $280K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 921 | $249K |
| CAHCardinal Health Inc. | 939 | $198K |
| GILDGILEAD SCIENCES, INC. | 1,411 | $197K |
| ABTABBOTT LABORATORIES | 1,663 | $171K |
| GMOptec International, Inc. | 1,352 | $101K |
| ELVElevance Health Inc. | 257 | $75K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.